1. Drug-eluting non-vascular stents for localised drug targeting in obstructive gastrointestinal cancers
2. European Medicines Agency. EMEA/CHMP/EWP/110540/2007. Guideline on the clinical and non clinical evaluation during the consultation procedure on medicinal substances contained in drug-eluting (medicinal substance-eluting) coronary stents. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003275.pdf. Accessed July 15, 2017.
3. Stents as a platform for drug delivery
4. Baron TH Enteral stents for the management of malignant colorectal obstruction. Available from: https://www.uptodate.com/contents/enteral-stents-for-the-management-of-malignant-colorectal-obstruction?source=search_result&search=enteral%20stent&selectedTitle=2~22. Accessed June 30, 2017.
5. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective